Evidence map›Paper›PMID 42646383›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Elemental Boron Nanoparticles for Boron-Neutron Capture Therapy of BT-474 Human Breast Cancer.

Evgenii L Zavjalov, Linga D Romanenko, Olga I Kichakova, Anna I Kasatova, Polina A Kotelnikova, Dmitry S Petrunya, Ekaterina V Barmina, Kuder O Aiyyzhy, Artem A Laktionov, Sergei M Klimentov and 10 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Evgenii L ZavjalovInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
Linga D RomanenkoInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
Olga I KichakovaInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.ORCID 0000-0002-8218-2690
Anna I KasatovaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0002-6641-9344
Polina A KotelnikovaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0001-6570-8147
Dmitry S PetrunyaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0009-0004-9075-5622
Ekaterina V BarminaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0003-0735-2896
Kuder O AiyyzhyProkhorov General Physics Institute, Russian Academy of Sciences, Moscow 119991, Russia.
Artem A LaktionovInstitute of Engineering Physics of Biomedicine, National Research Nuclear University "MEPhI", Moscow 115409, Russia.ORCID 0009-0009-8140-6988
Sergei M KlimentovP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.
Anton A PopovInstitute of Engineering Physics of Biomedicine, National Research Nuclear University "MEPhI", Moscow 115409, Russia.ORCID 0000-0001-8902-0371
Maria S GrigoryevaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0003-3759-5186
Timofey A BykovBudker Institute of Nuclear Physics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
Vasilisa V PodolyakoShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia.
Anastasia A FronyaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.
Egor I MavreshkoP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0009-0007-8357-3531
Danila A PokhorukovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia.ORCID 0009-0009-5684-0977
Sergey Yu TaskaevBudker Institute of Nuclear Physics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.ORCID 0000-0002-5313-2563
Sergey M DeyevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia.ORCID 0000-0002-3952-0631
Irina N ZavestovskayaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.

Funding

Russian Science Foundation 24-62-00018
6 · The paper itself

Abstract

Breast cancer remains one of the most common malignancies worldwide. Highly invasive HER2-positive breast cancer carries a high risk of metastasis and poses a significant therapeutic challenge. Boron neutron capture therapy (BNCT) may be an option for patients with this severe diagnosis. Here we evaluated the effectiveness of BNCT with elemental boron nanoparticles obtained by laser fragmentation and coated Silane-PEG-COOH and conjugated with the Affibody

Indexed as

Affibodyboron neutron capture therapy (BNCT)breast cancerBT-474elemental boron particles (BPs)HER2in vitroin vivomiceSCIDxenografts

Identifiers

PMID42646383
PMCPMC13515628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.